glp-1 anti-obesity PDF] Based Combination Therapy for Obesity and Diabetes GLP-1 Medications: Everything You Need

Acknowledgements We are grateful to Q

Bosch-Morell F et al

The FDA investigation into AC and GLP-1 RA drugs reported: The median age for people who developed AC was 55 years old Of the people who developed AC, 53% were female After starting the drug, 47% of patients developed AC within 90 days Cholelithiasis, or gallstones, was also added to the approval label

The process is simple: Complete a medical questionnaire

For non-Gaussian distributions, we used the Kruskal-Wallis with Dunns multiple comparisons

The combination lacks specific safety and efficacy data and should be investigated with appropriate caution in controlled research settings